Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RePST: Repeated Praziquantel for Schistosomiasis
NCT02868385Phase 3Completed
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of praziquantel in schistosomiasis mansoni, sponsored by Leiden University Medical Center. Started Oct 2018; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasis mansoni
Beyond the preview
Go deeper on NCT02868385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868385.